Literatur
-
1
Kannel W B, Hortland M C, McNamara P M. et al .
Menopause and risk of cardiovascular disease: the Framingham study.
Ann Intern Med.
1976;
85
447-452
-
2
The Writing Group for the PEPI Trial .
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
JAMA.
1995;
273
199-208
-
3
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
JAMA.
1998;
280
605-613
-
4
Writing Group for the Women's Health Initiative Investigators .
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial.
JAMA.
2002;
288
321-333
-
5
The Women’s Health Initiative Steering Committee .
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial.
JAMA.
2004;
291
1701-1712
-
6
Barrett-Connor E, Mosca L, Collins P. et al .
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women.
NEJM.
2006;
355
125-137
-
7 Gohlke-Bärwolf C, vonSchacky C. Stellenwert der Hormonersatz-Therapie zur Prävention der koronaren Herzerkrankung bei Frauen. In: Gohlke H, Schuler G (Hrsg) Empfehlungen zur Prävention von kardiovaskulären Erkrankungen. Z Kardiol 2005 94 (Suppl 3,III): 74-78
-
8
Gohlke-Bärwolf C, Regitz-Zagrosek V, Mueck R, Strasser A.
Leitlinien der Deutschen Gesellschaft für Kardiologie: Stellenwert der Hormonersatztherapie zur Prävention der Koronaren Herzerkrankung bei Frauen.
Z Kardiol.
2002;
91
430-435
-
9
Mosca L, Appel I J, Benjamin E J. et al .
Evidence-based guidelines for cardiovascular disease prevention in women.
Circulation.
2004;
109
672-693
-
10
Hsia J, Langer R D, Manson J A. et al .
Conjugated Equine Estrogens and Coronary Heart Disease, The Women’s Health Initiative.
Arch Intern Med.
2006;
166
357-365
Dr. med. Christa Gohlke-Bärwolf
Herz-Zentrum Bad Krozingen
Südring 15 · 79189 Bad Krozingen
Email: christa.gohlke-baerwolf@herzzentrum.de